Ctxr analyst report

Author: hjhf

August undefined, 2024

WebApr 10, 2024 · Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned CTXR a recommendation rating is 3. WebThe Citius Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, …

CTXR Citius Pharmaceuticals, Inc. - SeekingAlpha

WebBased on analysts offering 12 month price targets for CTXR in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . WebApr 11, 2024 · Their CTXR share price forecasts range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next year. This suggests a … iran currency to indian currency

Citius Pharma Stock (NASDAQ:CTXR), Analyst Ratings, Price

Web20 hours ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR) 04/04/23-11:25AM EST ... Web20 hours ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius … WebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. orcus winter

CTXR Insider Trading - Citius Pharmaceuticals Inc - Fintel

Live In Play

WebMar 31, 2024 · The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays ... WebApr 13, 2024 · The stock is rated as a Hold by 0 analyst(s), 3 recommend it as a Buy and 0 called the CTXR stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Buy. orcus xyz yugiohWebApr 3, 2024 · View CTXR revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... CTXR will report FY 2024 earnings on 12/13/2024. orcus white

"Web1 day ago · About CTXR Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on … " - Ctxr analyst report

Ctxr analyst report

CTXR Citius Pharmaceuticals Inc. Stock Price & News - WSJ

WebApr 17, 2024 · Many times after the initial analyst hyperbole has died and lockups have expired, these same companies can be had for .30 to .50 cents on the dollar from when the shares went public. WebApr 12, 2024 · Valuation is complex, but we're helping make it simple. Find out whether Citius Pharmaceuticals is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.. View the Free Analysis

Did you know?

WebMar 30, 2024 · CTXR Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq CTXR U.S.: Nasdaq Citius Pharmaceuticals Inc. Watch list Create CTXR Alert … WebCitius Pharma Stock (NASDAQ:CTXR), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks.

WebApr 6, 2024 · A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebCTXR 2M Long Term test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a …

Web2 days ago · Company Profile CTXR. Business Description. Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique … WebCitius Pharmaceuticals (CTXR) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Citius Pharmaceuticals reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.286%.

WebThe 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The …

Web18 hours ago · View Citius Pharmaceuticals, Inc CTXR investment & stock information. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time … orcus904WebFeb 20, 2024 · An analysis of the Citius Pharmaceuticals Inc. (NASDAQ:CTXR) stock in terms of its daily trading volume indicates that the 3-month average is 826.91K. However, this figure increases on the past 10-day timeline to an average of 0.7 million. Current records show that the company has 146.15M in outstanding shares. orcus white punchWebCitius Pharmaceuticals, Inc. (CTXR) Analyst Ratings, Estimates & Forecasts - Yahoo Finance U.S. markets closed S&P 500 4,105.02 +14.64(+0.36%) Dow 30 33,485.29 … iran currency to pakistanWebMar 27, 2024 · View our latest analysis for Citius Pharmaceuticals. According to some industry analysts covering Citius Pharmaceuticals, breakeven is near. They anticipate the company to incur a final loss in ... orcus\u0027 wandWebIn this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTXR / Citius Pharmaceuticals Inc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical . iran currency to randWebApr 6, 2024 · A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … orcus\\u0027 wandWebCTXR Complete Citius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. orcus tiefling